Bluejay Diagnostics (BJDX) Non Operating Income (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Non Operating Income of $19590.0 for Q1 2026, down 19.98% on a YoY basis from $24482.0 in Q1 2025, and down 38.66% sequentially from $31935.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Non Operating Income (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Non Operating Income data on file, last reported at $19590.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 19.98% year-over-year to $19590.0; the trailing twelve-month figure through Mar 2026 stood at $99597.0 (up 115.98% YoY), and the FY2025 full-year result was $104489.0, up 119.06% from the prior year.
- Non Operating Income fell to $19590.0 in Q1 2026, from $31935.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $139729.0 in Q1 2023 to a low of -$580119.0 in Q2 2024.
- A 5-year average of -$2702.4 and a median of $43235.0 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 176.9% in 2022 and sank 741.85% in 2024, its largest moves.
- Tracing BJDX's Non Operating Income over 5 years: stood at $67358.0 in 2022, then advanced by 24.68% to $83982.0 in 2023, then sank by 37.3% to $52654.0 in 2024, then sank by 39.35% to $31935.0 in 2025, then slumped by 38.66% to $19590.0 in 2026.
- Business Quant data shows BJDX's Non Operating Income at $19590.0 in Q1 2026, $31935.0 in Q4 2025, and $19315.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 19,590.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,590.00 |
| Dec 31, 2025 | 31,935.00 |
| Sep 30, 2025 | 19,315.00 |
| Jun 30, 2025 | 28,757.00 |
| Mar 31, 2025 | 24,482.00 |
| Dec 31, 2024 | 52,654.00 |
| Sep 30, 2024 | -120,352.00 |
| Jun 30, 2024 | -580,119.00 |
| Mar 31, 2024 | 99,640.00 |
| Dec 31, 2023 | 83,982.00 |
| Sep 30, 2023 | 43,235.00 |
| Jun 30, 2023 | 90,383.00 |
| Mar 31, 2023 | 139,729.00 |
| Dec 31, 2022 | 67,358.00 |
| Sep 30, 2022 | -149,711.00 |
| Jun 30, 2022 | 48,323.00 |
| Mar 31, 2022 | 54,858.00 |
| Dec 31, 2021 | -87,591.00 |
| Sep 30, 2021 | -235,393.00 |
| Jun 30, 2021 | 25,839.00 |